[ad_1]
Risankizumab demonstrates effectiveness in achieving steroid-free clinical remission in the real-world cohort of patients with refractory Crohn’s disease, with a favourable safety profile.
Medscape News UK
[ad_2]
Source link : https://www.medscape.com/viewarticle/real-world-data-show-efficacy-risankizumab-refractory-crohns-2026a1000kgx?src=rss
Author :
Publish date : 2026-06-19 12:00:00
Copyright for syndicated content belongs to the linked Source.